Terms: = Lung cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta
46 results:
1. Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.
Woo J; Lu D; Lewandowski A; Xu H; Serrano P; Healey M; Yates DP; Beste MT; Libby P; Ridker PM; Steensma DP
Blood Adv; 2023 Dec; 7(24):7471-7484. PubMed ID: 37934948
[TBL] [Abstract] [Full Text] [Related]
2. Development and Validation of a Prognosis-Prediction Signature for Patients with lung Adenocarcinoma Based on 11 Telomere-Related Genes.
Liu J; Sha S; Wang J; Gu X; Du M; Lu X
Front Biosci (Landmark Ed); 2023 Oct; 28(10):254. PubMed ID: 37919072
[TBL] [Abstract] [Full Text] [Related]
3. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
[TBL] [Abstract] [Full Text] [Related]
4. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
[TBL] [Abstract] [Full Text] [Related]
5. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract] [Full Text] [Related]
6. First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews.
Wu R; Liu S; Lv G; Deng C; Wang R; Zhang S; Zhu D; Wang L; Lei Y; Luo Z
Anticancer Drugs; 2023 Feb; 34(2):294-301. PubMed ID: 36730620
[TBL] [Abstract] [Full Text] [Related]
7. Clear cell stromal tumor of the lung with multinucleated giant cells: a report of a case with YAP1-TFE3 fusion.
Jakša R; Stružinská I; Kendall Bártů M; Trča S; Matěj R; Dundr P
Diagn Pathol; 2023 Jan; 18(1):9. PubMed ID: 36707859
[TBL] [Abstract] [Full Text] [Related]
8. [Thoracic paravertebral block improves the prognosis of patients undergoing lung cancer surgery].
Mai D; Rao Y; Chen D; Li Q; He W; Zeng W; Xing W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1526-1531. PubMed ID: 36329587
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study.
Bironzo P; Melocchi L; Monica V; Trebeschi D; Barbieri F; Maiello E; Migliorino MR; Lombardi A; Tiseo M; Righi L; Graziano P; Rossi G; Novello S
Pathologica; 2022 Aug; 114(4):278-287. PubMed ID: 36083243
[TBL] [Abstract] [Full Text] [Related]
10. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
[TBL] [Abstract] [Full Text] [Related]
11. Ethnic Differences in cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.
Yu D; Wang Z; Cai Y; McBride K; Osuagwu UL; Pickering K; Baker J; Cutfield R; Orr-Walker BJ; Sundborn G; Jameson MB; Zhao Z; Simmons D
JAMA Netw Open; 2022 Feb; 5(2):e2147171. PubMed ID: 35129595
[TBL] [Abstract] [Full Text] [Related]
12. Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.
Canals J; Navarro A; Vila C; Canals JM; Díaz T; Acosta-Plasencia M; Cros-Font C; Han B; He Y; Monzó M
J Exp Clin Cancer Res; 2022 Jan; 41(1):37. PubMed ID: 35081981
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Characterization of Peritoneal Mesotheliomas.
Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
[TBL] [Abstract] [Full Text] [Related]
14. Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.
Cheung M; Kadariya Y; Sementino E; Hall MJ; Cozzi I; Ascoli V; Ohar JA; Testa JR
Hum Mol Genet; 2021 Aug; 30(18):1750-1761. PubMed ID: 34008015
[TBL] [Abstract] [Full Text] [Related]
15. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
[TBL] [Abstract] [Full Text] [Related]
16. Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
Tlemsani C; Takahashi N; Pongor L; Rajapakse VN; Tyagi M; Wen X; Fasaye GA; Schmidt KT; Desai P; Kim C; Rajan A; Swift S; Sciuto L; Vilimas R; Webb S; Nichols S; Figg WD; Pommier Y; Calzone K; Steinberg SM; Wei JS; Guha U; Turner CE; Khan J; Thomas A
Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33504652
[TBL] [Abstract] [Full Text] [Related]
17. XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genes.
Singh A; Singh N; Behera D; Sharma S
Future Oncol; 2019 Nov; 15(33):3845-3859. PubMed ID: 31709821
[No Abstract] [Full Text] [Related]
18. Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell lung cancer.
Dong J; Wang X; Yu Y; Yan X; Cui JW
Chin Med J (Engl); 2018 Aug; 131(16):1904-1908. PubMed ID: 30082520
[TBL] [Abstract] [Full Text] [Related]
19. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
[TBL] [Abstract] [Full Text] [Related]
20. Genetic Investigation of Polymorphic OGG1 and mutyh Genes Towards Increased Susceptibility in lung Adenocarcinoma and its Impact on Overall Survival of lung cancer Patients Treated with Platinum Based Chemotherapy.
Singh A; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
[TBL] [Abstract] [Full Text] [Related]
[Next]
